{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:49:32Z","timestamp":1790696972817,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T00:00:00Z","timestamp":1555891200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s10620-019-05615-5","type":"journal-article","created":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T11:03:21Z","timestamp":1555931001000},"page":"2757-2768","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Management of Thrombocytopenia in Patients with Chronic Liver Disease"],"prefix":"10.1007","volume":"64","author":[{"given":"Sammy","family":"Saab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Robert S.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,22]]},"reference":[{"key":"5615_CR1","unstructured":"Thrombocytopenia. National Heart, Lung, and Blood Institute website. \n                    www.nhlbi.nih.gov\/health-topics\/thrombocytopenia\n                    \n                  . Accessed August 10, 2018."},{"key":"5615_CR2","first-page":"612","volume":"85","author":"RL Gauer","year":"2012","unstructured":"Gauer RL, Braun MM. Thrombocytopenia. Am Fam Physician. 2012;85:612\u2013622.","journal-title":"Am Fam Physician"},{"key":"5615_CR3","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/0306-9877(88)90121-1","volume":"26","author":"P Aseni","year":"1988","unstructured":"Aseni P, Frangi M, Beati C, Vertemati M, Romani F. Is thrombocytopenia in liver failure dependent on an inadequate synthesis of thrombopoietic stimulating factor by the liver? Med Hypotheses. 1988;26:217\u2013219. \n                    https:\/\/doi.org\/10.1016\/0306-9877(88)90121-1\n                    \n                  .","journal-title":"Med Hypotheses"},{"key":"5615_CR4","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1172\/JCI105380","volume":"45","author":"RH Aster","year":"1966","unstructured":"Aster RH. Pooling of platelets in the spleen: role in the pathogenesis of \u201chypersplenic\u201d thrombocytopenia. J Clin Invest. 1966;45:645\u2013657. \n                    https:\/\/doi.org\/10.1172\/JCI105380\n                    \n                  .","journal-title":"J Clin Invest"},{"key":"5615_CR5","unstructured":"Chronic liver disease and cirrhosis. Centers for Disease Control and Prevention website. \n                    www.cdc.gov\/nchs\/fastats\/liver-disease.htm\n                    \n                  . Updated October 6, 2016. Accessed August 10, 2018."},{"key":"5615_CR6","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1111\/j.1572-0241.2000.02325.x","volume":"95","author":"FN Bashour","year":"2000","unstructured":"Bashour FN, Teran JC, Mullen KD. Prevalence of peripheral blood cytopenias (hypersplenism) in patients with nonalcoholic chronic liver disease. Am J Gastroenterol. 2000;95:2936\u20132939. \n                    https:\/\/doi.org\/10.1111\/j.1572-0241.2000.02325.x\n                    \n                  .","journal-title":"Am J Gastroenterol"},{"key":"5615_CR7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1365-2036.2007.03505.x","volume":"26","author":"RS Brown Jr","year":"2007","unstructured":"Brown RS Jr. Review article: a pharmacoeconomic analysis of thrombocytopenia in chronic liver disease. Aliment Pharmacol Ther. 2007;26:41\u201348. \n                    https:\/\/doi.org\/10.1111\/j.1365-2036.2007.03505.x\n                    \n                  .","journal-title":"Aliment Pharmacol Ther"},{"key":"5615_CR8","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3111\/13696998.2011.632463","volume":"15","author":"F Poordad","year":"2012","unstructured":"Poordad F, Theodore D, Sullivan J, Grotzinger K. Evaluating medical resource utilization and costs associated with thrombocytopenia in chronic liver disease patients. J Med Econ. 2012;15:112\u2013124. \n                    https:\/\/doi.org\/10.3111\/13696998.2011.632463\n                    \n                  .","journal-title":"J Med Econ"},{"key":"5615_CR9","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.3748\/wjg.v20.i10.2595","volume":"20","author":"H Hayashi","year":"2014","unstructured":"Hayashi H, Beppu T, Shirabe K, Maehara Y, Baba H. Management of thrombocytopenia due to liver cirrhosis: a review. World J Gastroenterol. 2014;20:2595\u20132605. \n                    https:\/\/doi.org\/10.3748\/wjg.v20.i10.2595\n                    \n                  .","journal-title":"World J Gastroenterol"},{"key":"5615_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1634\/theoncologist.6-suppl_5-15","volume":"6","author":"GD Demetri","year":"2001","unstructured":"Demetri GD. Targeted approaches for the treatment of thrombocytopenia. Oncologist. 2001;6:15\u201323. \n                    https:\/\/doi.org\/10.1634\/theoncologist.6-suppl_5-15\n                    \n                  .","journal-title":"Oncologist"},{"key":"5615_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1365-2036.2007.03510.x","volume":"26","author":"F Poordad","year":"2007","unstructured":"Poordad F. Review article: thrombocytopenia in chronic liver disease. Aliment Pharmacol Ther. 2007;26:5\u201311. \n                    https:\/\/doi.org\/10.1111\/j.1365-2036.2007.03510.x\n                    \n                  .","journal-title":"Aliment Pharmacol Ther"},{"key":"5615_CR12","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.jhep.2013.03.040","volume":"59","author":"EB Tapper","year":"2013","unstructured":"Tapper EB, Robson SC, Malik R. Coagulopathy in cirrhosis\u2014the role of the platelet in hemostasis. J Hepatol. 2013;59:889\u2013890. \n                    https:\/\/doi.org\/10.1016\/j.jhep.2013.03.040\n                    \n                  .","journal-title":"J Hepatol"},{"key":"5615_CR13","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1111\/j.1572-0241.1999.01231.x","volume":"94","author":"T Kawasaki","year":"1999","unstructured":"Kawasaki T, Takeshita A, Souda K, et al. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis. Am J Gastrolenterol. 1999;94:1918\u20131922. \n                    https:\/\/doi.org\/10.1111\/j.1572-0241.1999.01231.x\n                    \n                  .","journal-title":"Am J Gastrolenterol"},{"key":"5615_CR14","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/ajh.2830500305","volume":"50","author":"J Perreira","year":"1995","unstructured":"Perreira J, Accatino L, Alfaro J, Brahm J, Hidalgo P, Mezzano D. Platelet autoantibodies in patients with chronic liver disease. Am J Hematol. 1995;50:173\u2013178.","journal-title":"Am J Hematol"},{"key":"5615_CR15","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.jhep.2008.03.009","volume":"48","author":"N Afdhal","year":"2008","unstructured":"Afdhal N, McHutchison J, Brown R, et al. Thrombocytopenia associated with chronic liver disease. J Hepatol. 2008;48:1000\u20131007. \n                    https:\/\/doi.org\/10.1016\/j.jhep.2008.03.009\n                    \n                  .","journal-title":"J Hepatol"},{"key":"5615_CR16","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.cgh.2010.03.025","volume":"8","author":"LB Seeff","year":"2010","unstructured":"Seeff LB, Everson GT, Morgan TR, et al. Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial. Clin Gastroenterol Hepatol. 2010;8:877\u2013883.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5615_CR17","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/00004836-198210000-00011","volume":"4","author":"P Sharma","year":"1982","unstructured":"Sharma P, McDonald GB, Banaji M. The risk of bleeding after percutaneous liver biopsy: relation to platelet count. J Clin Gastroenterol. 1982;4:451\u2013453.","journal-title":"J Clin Gastroenterol"},{"key":"5615_CR18","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.cgh.2010.06.018","volume":"8","author":"EG Giannini","year":"2010","unstructured":"Giannini EG, Greco A, Marenco S, Andorno E, Valente U, Savarino V. Incidence of bleeding following invasive procedures in patients with thrombocytopenia and advanced liver disease. Clin Gastroenterol Hepatol. 2010;8:899\u2013902. \n                    https:\/\/doi.org\/10.1016\/j.cgh.2010.06.018\n                    \n                  .","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5615_CR19","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1155\/2014\/532191","volume":"28","author":"VG Gangireddy","year":"2014","unstructured":"Gangireddy VG, Kanneganti PC, Sridhar S, Talla S, Coleman T. Management of thrombocytopenia in advanced liver disease. Can J Gastroenterol Hepatol. 2014;28:558\u2013564.","journal-title":"Can J Gastroenterol Hepatol"},{"key":"5615_CR20","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/00001721-199104000-00026","volume":"2","author":"MF Murphy","year":"1991","unstructured":"Murphy MF, Waters AH. Clinical aspects of platelet transfusions. Blood Coagul Fibrinolysis. 1991;2:389\u2013396.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"5615_CR21","doi-asserted-by":"publisher","first-page":"3228","DOI":"10.3748\/wjg.v23.i18.3228","volume":"23","author":"T Kurokawa","year":"2017","unstructured":"Kurokawa T, Ohkohchi N. Platelets in liver disease, cancer and regeneration. World J Gastroentol. 2017;23:3228\u20133239. \n                    https:\/\/doi.org\/10.3748\/wjg.v23.i18.3228\n                    \n                  .","journal-title":"World J Gastroentol"},{"key":"5615_CR22","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1200\/JCO.2017.76.1734","volume":"36","author":"CA Schiffer","year":"2018","unstructured":"Schiffer CA, Bohlke K, Delaney M, et al. Platelet transfusion for patients with cancer: American society of clinical oncology clinical practice guidelines update. J Clin Oncol. 2018;36:283\u2013301. \n                    https:\/\/doi.org\/10.1200\/JCO.2017.76.1734\n                    \n                  .","journal-title":"J Clin Oncol"},{"key":"5615_CR23","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1182\/blood.V81.6.1411.1411","volume":"81","author":"E Beutler","year":"1993","unstructured":"Beutler E. Platelet transfusions: the 20,000\/microL trigger. Blood. 1993;81:1411\u20131413.","journal-title":"Blood"},{"key":"5615_CR24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3410\/m2-5","volume":"2","author":"N Blumberg","year":"2010","unstructured":"Blumberg N, Heal JM, Phillips GL. Platelet transfusions: trigger, dose, benefits, and risks. F1000 Med Rep. 2010;2:5. \n                    https:\/\/doi.org\/10.3410\/m2-5\n                    \n                  .","journal-title":"F1000 Med Rep"},{"key":"5615_CR25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1365-2036.2007.03511.x","volume":"26","author":"NH Afdhal","year":"2007","unstructured":"Afdhal NH, McHutchison J. Review article: pharmacological approaches for the treatment of thrombocytopenia in patients with chronic liver disease and hepatitis C infection. Aliment Pharmacol Ther. 2007;26:29\u201339. \n                    https:\/\/doi.org\/10.1111\/j.1365-2036.2007.03511.x\n                    \n                  .","journal-title":"Aliment Pharmacol Ther"},{"key":"5615_CR26","first-page":"6","volume":"17","author":"EM Wolber","year":"2002","unstructured":"Wolber EM, Jelkmann W. Thrombopoietin: the novel hepatic hormone. News Physiol Sci. 2002;17:6\u201310.","journal-title":"News Physiol Sci"},{"key":"5615_CR27","unstructured":"Nplate [package insert]. Thousand Oaks, CA: Amgen Inc; 2018."},{"key":"5615_CR28","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1440-1746.2012.07246.x","volume":"28","author":"MM Moussa","year":"2013","unstructured":"Moussa MM, Mowafy N. Preoperative use of romiplostim in thrombocytopenic patients with chronic hepatitis C and liver cirrhosis. J Gastroenterol Hepatol. 2013;28:335\u2013341. \n                    https:\/\/doi.org\/10.1111\/j.1440-1746.2012.07246.x\n                    \n                  .","journal-title":"J Gastroenterol Hepatol"},{"key":"5615_CR29","first-page":"97","volume":"37","author":"G Buccoliero","year":"2014","unstructured":"Buccoliero G, Urbano T, Mazza P, Resta F, Pisconti S. Romiplostim for severe thrombocytopenia in the treatment of chronic hepatitis C virus infection: a new option for clinicians? New Microbiol. 2014;37:97\u2013101.","journal-title":"New Microbiol"},{"key":"5615_CR30","unstructured":"Promacta [package insert]. East Hanover, NJ: Novartis Pharmaceuticals Corporation; 2018."},{"key":"5615_CR31","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1053\/j.gastro.2013.10.012","volume":"146","author":"NH Afdhal","year":"2014","unstructured":"Afdhal NH, Dusheiko GM, Giannini EG, et al. Eltrombopag increases platelet numbers in thrombocytopenic patients with HCV infection and cirrhosis, allowing for effective antiviral therapy. Gastroenterology. 2014;146:442\u2013452. \n                    https:\/\/doi.org\/10.1053\/j.gastro.2013.10.012\n                    \n                  .","journal-title":"Gastroenterology"},{"key":"5615_CR32","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1056\/NEJMoa1110709","volume":"367","author":"NH Afdhal","year":"2012","unstructured":"Afdhal NH, Giannini EG, Tayyab G, et al. ELEVATE Study Group. Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia. N Engl J Med. 2012;367:716\u2013724. \n                    https:\/\/doi.org\/10.1056\/nejmoa1110709\n                    \n                  .","journal-title":"N Engl J Med"},{"key":"5615_CR33","unstructured":"Doptelet [package insert]. Durham, NC: Dova Pharmaceuticals Inc; 2018."},{"key":"5615_CR34","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1053\/j.gastro.2018.05.025","volume":"155","author":"N Terrault","year":"2018","unstructured":"Terrault N, Chen YC, Izumi N, et al. Avatrombopag before procedures reduces need for platelet transfusion in patients with chronic liver disease and thrombocytopenia. Gastroenterology. 2018;155:703\u2013718. \n                    https:\/\/doi.org\/10.1053\/j.gastro.2018.05.025\n                    \n                  .","journal-title":"Gastroenterology"},{"key":"5615_CR35","unstructured":"Mulpleta [package insert]. Florham Park, NJ: Shionogi Inc.; 2018."},{"key":"5615_CR36","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s40265-015-0525-4","volume":"76","author":"ES Kim","year":"2016","unstructured":"Kim ES. Lusutrombopag: first global approval. Drugs. 2016;76:155\u2013158. \n                    https:\/\/doi.org\/10.1007\/s40265-015-0525-4\n                    \n                  .","journal-title":"Drugs"},{"key":"5615_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2018.11.047","author":"H Hidaka","year":"2018","unstructured":"Hidaka H, Kurosaki M, Tanaka H, et al. Lusutrombopag reduces the need for platelet transfusion in patients with thrombocytopenia undergoing invasive procedures. Clin Gastroenterol Hepatol. 2018;. \n                    https:\/\/doi.org\/10.1016\/j.cgh.2018.11.047\n                    \n                  .","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5615_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30561","author":"M Peck-Radosavljevic","year":"2019","unstructured":"Peck-Radosavljevic M, Simon K, Iacobellis A, et al. Lusutrombopag for the treatment of thrombocytopenia in patients with chronic liver disease undergoing invasive procedures (L-PLUS-2). Hepatology. 2019;. \n                    https:\/\/doi.org\/10.1002\/hep.30561\n                    \n                  .","journal-title":"Hepatology"},{"key":"5615_CR39","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.dld.2018.06.005","volume":"51","author":"L Loffredo","year":"2019","unstructured":"Loffredo L, Violo F. Thrombopoietin receptor agonists and risk of portal vein thrombosis in patients with liver disease and thrombocytopenia: a meta-analysis. Dig Liv Dis. 2019;51:24\u201327.","journal-title":"Dig Liv Dis"},{"key":"5615_CR40","doi-asserted-by":"publisher","first-page":"160","DOI":"10.4329\/wjr.v6.i5.160","volume":"6","author":"TA Hadduck","year":"2014","unstructured":"Hadduck TA, McWilliams JP. Partial splenic artery embolization in cirrhotic patients. World J Radiol. 2014;6:160\u2013168. \n                    https:\/\/doi.org\/10.4329\/wjr.v6.i5.160\n                    \n                  .","journal-title":"World J Radiol"},{"key":"5615_CR41","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/hep.22742","volume":"49","author":"DC Rockey","year":"2009","unstructured":"Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD. American association for the study of liver diseases. Liver Biopsy Hepatol. 2009;49:1017\u20131044. \n                    https:\/\/doi.org\/10.1002\/hep.22742\n                    \n                  .","journal-title":"Liver Biopsy Hepatol"},{"key":"5615_CR42","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.jvir.2012.02.012","volume":"23","author":"IJ Patel","year":"2012","unstructured":"Patel IJ, Davidson JC, Nikolic B, et al. Standards of practice committee, with cardiovascular and interventional radiological society of Europe (CIRSE) endorsement. Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image guided interventions. J Vasc Interv Radiol. 2012;23:727\u2013736. \n                    https:\/\/doi.org\/10.1016\/j.jvir.2012.02.012\n                    \n                  .","journal-title":"J Vasc Interv Radiol"},{"key":"5615_CR43","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.gie.2012.03.252","volume":"76","author":"T Ben-Menachem","year":"2012","unstructured":"Ben-Menachem T, Decker GA, Early DS, et al. ASGE standards of practice committee. Adverse events of upper GI endoscopy. Gastrointest Endosc. 2012;76:707\u2013718. \n                    https:\/\/doi.org\/10.1016\/j.gie.2012.03.252\n                    \n                  .","journal-title":"Gastrointest Endosc"},{"key":"5615_CR44","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1053\/j.seminhematol.2010.04.003","volume":"47","author":"HL Tillmann","year":"2010","unstructured":"Tillmann HL, McHutchison JG. Use of thrombopoietic agents for the thrombocytopenia of liver disease. Semin Hematol. 2010;47:266\u2013273. \n                    https:\/\/doi.org\/10.1053\/j.seminhematol.2010.04.003\n                    \n                  .","journal-title":"Semin Hematol"},{"key":"5615_CR45","doi-asserted-by":"publisher","first-page":"S347","DOI":"10.3816\/CLM.2009.s.034","volume":"9","author":"DJ Kuter","year":"2009","unstructured":"Kuter DJ. New thrombopoietic growth factors. Clin Lymphoma Myeloma. 2009;9:S347\u2013S356. \n                    https:\/\/doi.org\/10.3816\/CLM.2009.s.034\n                    \n                  .","journal-title":"Clin Lymphoma Myeloma"},{"key":"5615_CR46","first-page":"39","volume":"8","author":"O Mitchell","year":"2016","unstructured":"Mitchell O, Feldman DM, Diakow M, et al. The pathophysiology of thrombocytopenia in chronic liver disease. Hepat Med. 2016;8:39\u201350.","journal-title":"Hepat Med"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-019-05615-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-019-05615-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-019-05615-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T19:11:01Z","timestamp":1587409861000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-019-05615-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,22]]},"references-count":46,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["5615"],"URL":"https:\/\/doi.org\/10.1007\/s10620-019-05615-5","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,22]]},"assertion":[{"value":"4 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors of this manuscript have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}